Takashi Takei Selected Research

Lipoid Nephrosis (Glomerulonephritis, Minimal Change)

1/2018	Rituximab as a Therapeutic Option for Steroid-Sensitive Minimal Change Nephrotic Syndrome in Adults.
2/2016	Amelioration of the adverse effects of prednisolone by rituximab treatment in adults with steroid-dependent minimal-change nephrotic syndrome.
12/2014	Long-term prognosis of adult patients with steroid-dependent minimal change nephrotic syndrome following rituximab treatment.
5/2013	Effect of single-dose rituximab on steroid-dependent minimal-change nephrotic syndrome in adults.
8/2012	Severity of nephrotic IgA nephropathy according to the Oxford classification.
12/2011	Induction of remission following a single dose of rituximab alone in a patient with minimal change nephrotic syndrome.
10/2011	Rituximab and minimal change nephrotic syndrome: a therapeutic option.
1/2011	Effect of single-dose rituximab on primary glomerular diseases.
1/2010	Combined cyclosporine and prednisolone therapy in adult patients with the first relapse of minimal-change nephrotic syndrome.
1/2010	Risedronate therapy for the prevention of steroid-induced osteoporosis in patients with minimal-change nephrotic syndrome.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Takashi Takei Research Topics

Disease

29	Proteinuria 01/2020 - 01/2007
19	IGA Glomerulonephritis (IGA Nephropathy) 04/2016 - 03/2002
13	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2020 - 01/2008
12	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 01/2018 - 09/2007
10	Chronic Renal Insufficiency 09/2021 - 01/2008
8	Glomerulonephritis 08/2017 - 01/2005
6	Chronic Kidney Failure (Chronic Renal Failure) 09/2019 - 12/2010
6	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 03/2019 - 01/2008
6	Hematuria 04/2016 - 01/2007
4	Hypertension (High Blood Pressure) 08/2022 - 01/2004
4	Renal Insufficiency (Renal Failure) 06/2021 - 01/2008
4	Membranous Glomerulonephritis (Membranous Nephropathy) 10/2017 - 01/2008
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2015 - 12/2007
3	Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II) 01/2021 - 01/2011
3	Infections 01/2016 - 01/2007
3	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2016 - 01/2005
3	Hyperuricemia 10/2015 - 07/2014
3	Hemorrhage 01/2008 - 01/2007
3	Vascular Calcification 01/2008 - 01/2004
2	IgA Vasculitis (Purpura, Schoenlein Henoch) 06/2021 - 01/2021
2	Nephritis 06/2021 - 01/2008
2	Kidney Diseases (Kidney Disease) 01/2021 - 07/2014
2	Disease Progression 01/2020 - 12/2014
2	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 01/2020 - 01/2012
2	Exanthema (Rash) 01/2018 - 10/2011
2	Chills 01/2018 - 10/2011
2	Osteoporosis 02/2016 - 01/2010
2	Microscopic Polyangiitis 01/2016 - 01/2008
2	Fatigue 01/2016 - 01/2007
2	Fever (Fevers) 01/2016 - 01/2007
2	Thrombocytopenia (Thrombopenia) 11/2015 - 01/2007
2	Sclerosis 01/2015 - 01/2008
2	Fibrosis (Cirrhosis) 08/2012 - 08/2009
2	Acute Kidney Injury (Acute Renal Failure) 04/2012 - 01/2005
2	Thrombotic Thrombocytopenic Purpura 01/2010 - 01/2007
2	Vasculitis (Vasculitides) 01/2010 - 08/2009
2	Lupus Nephritis 01/2010 - 01/2009
1	Pathologic Complete Response 01/2020
1	Hepatitis 09/2019
1	Anemia 09/2019
1	Chronic Disease (Chronic Diseases) 09/2019
1	Human Influenza (Influenza) 09/2019
1	Necrosis 09/2019
1	Septic Shock (Toxic Shock Syndrome) 09/2019
1	Birth Weight (Birth Weights) 03/2016
1	Diabetes Mellitus 02/2016
1	Weight Loss (Weight Reduction) 01/2016
1	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 01/2016
1	Rheumatic Fever (Acute Articular Rheumatism) 01/2016
1	Malnutrition (Nutritional Deficiencies) 12/2015
1	Thiamine Deficiency 12/2015
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 11/2015

Drug/Important Bio-Agent (IBA)

25	SteroidsIBA 06/2021 - 01/2005
15	Rituximab (Mabthera)FDA Link 01/2020 - 01/2009
13	CreatinineIBA 03/2020 - 01/2007
9	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 08/2017 - 01/2005
9	Proteins (Proteins, Gene)FDA Link 06/2016 - 09/2008
7	Immunoglobulin A (IgA)IBA 01/2021 - 01/2005
6	Adrenal Cortex Hormones (Corticosteroids)IBA 06/2021 - 08/2009
6	Prednisolone (Predate)FDA LinkGeneric 04/2016 - 09/2007
6	Uric Acid (Urate)IBA 10/2015 - 01/2012
5	Immunoglobulin G (IgG)IBA 08/2017 - 08/2009
4	Serum AlbuminIBA 02/2013 - 08/2009
3	Immunosuppressive Agents (Immunosuppressants)IBA 01/2018 - 10/2011
3	Immunoglobulins (Immunoglobulin)IBA 08/2017 - 01/2005
3	Immunoglobulin M (IgM)IBA 08/2017 - 08/2009
3	Tacrolimus (Prograf)FDA LinkGeneric 01/2016 - 01/2009
3	C-Reactive ProteinIBA 10/2015 - 01/2007
3	Allopurinol (Remid)FDA LinkGeneric 10/2015 - 07/2014
3	AlbuminsIBA 06/2015 - 01/2010
3	Angiotensin Receptor AntagonistsIBA 10/2011 - 09/2008
3	Pharmaceutical PreparationsIBA 01/2011 - 09/2005
3	SelectinsIBA 06/2006 - 03/2002
2	Antihypertensive Agents (Antihypertensives)IBA 08/2022 - 01/2008
2	Febuxostat FDA Link 10/2015 - 11/2014
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2014 - 01/2008
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 10/2011 - 12/2007
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 10/2011 - 09/2008
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2010 - 01/2008
2	thiamine triphosphorate (TTP)IBA 01/2010 - 01/2007
1	Indicators and Reagents (Reagents)IBA 08/2022
1	Azathioprine (Imuran)FDA LinkGeneric 06/2021
1	mizoribineIBA 01/2021
1	Cystatin CIBA 03/2020
1	Transaminases (Aminotransferases)IBA 09/2019
1	NucleoproteinsIBA 09/2019
1	Oxygen (Dioxygen)IBA 09/2019
1	Histones (Histone)IBA 03/2019
1	prednylidene (Pred)IBA 02/2016
1	Polysaccharides (Glycans)IBA 01/2016
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2016
1	Thiamine (Aneurin)FDA Link 12/2015

Therapy/Procedure

29	Therapeutics 01/2021 - 01/2005
12	Renal Dialysis (Hemodialysis) 09/2021 - 01/2002
4	Aftercare (After-Treatment) 01/2013 - 01/2007
3	Tonsillectomy 10/2015 - 04/2013
2	Transplantation 01/2020 - 08/2009
2	Plasma Exchange 01/2010 - 01/2007
1	Plasmapheresis 01/2020
1	Glycemic Control 02/2016